DXM + Terbinafine, oral

https://dxm-atlas.org/en/interactions/terbinafine-oral/

Compare

Key points for this combination

A human study used a probe substance to assess CYP2D6 activity and showed inhibition by terbinafine [23]. High confidence in direct evidence (D) refers to that enzyme-test result. The test did not measure total DXM exposure over time (AUC) or clinical outcomes.

General concepts in this text

Enzyme

A protein that helps chemical transformations in cells.

A transformation can build or break down a substance.

Sources: Enzyme

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

AUC

Area under the graph of a drug’s plasma concentration over time.

It combines concentration and time to describe drug exposure over an interval.

Sources: AUC

Drug exposure

Description of how much of a medicine is present in the body, using its concentrations.

Cmax describes the concentration peak; AUC combines concentrations over time.

Sources: Drug exposure

How well is this understood?

Mechanism confidence: high

Confidence in the mechanism: high

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: high

Confidence in direct human evidence involving DXM: high

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Measurements of drug concentration or metabolism.

How to read ratings and study limits

How do the substances interact?

Can the amount reaching the body change?

Mechanism: 2D6 — CYP2D6 metabolism
ⓘ

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

What remains unknown?

*Direct metabolic-phenotyping evidence of CYP2D6 inhibition. High confidence H concerns that measured endpoint [23].

Sources

Check the review’s wording

*Direct metabolic-phenotyping evidence of CYP2D6 inhibition. High confidence H concerns that measured endpoint [23].

Combination row in the review: 2D6 — CYP2D6 metabolism

Evidence and sources

Research publication

[23] · Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects · 2001

Finding [23]

What was found?

*Direct metabolic-phenotyping evidence of CYP2D6 inhibition. High confidence H concerns that measured endpoint [23].

Scientific review: 8. Antihistamines and modifiers of metabolism

Related entries

Reference

Open the source and related combinations →